Page last updated: 2024-10-25

chlorpromazine and Degenerative Diseases, Central Nervous System

chlorpromazine has been researched along with Degenerative Diseases, Central Nervous System in 1 studies

Chlorpromazine: The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup.
chlorpromazine : A substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropanamine moiety.

Research Excerpts

ExcerptRelevanceReference
"While neurodegenerative diseases affect millions of patients worldwide, there are insufficient available therapeutics to halt or slow down the progression of these diseases."1.72Design, Synthesis, and Biological Evaluation of Potent 20S Proteasome Activators for the Potential Treatment of α-Synucleinopathies. ( Jones, CL; Staerz, SD; Tepe, JJ, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Staerz, SD1
Jones, CL1
Tepe, JJ1

Other Studies

1 other study available for chlorpromazine and Degenerative Diseases, Central Nervous System

ArticleYear
Design, Synthesis, and Biological Evaluation of Potent 20S Proteasome Activators for the Potential Treatment of α-Synucleinopathies.
    Journal of medicinal chemistry, 2022, 05-12, Volume: 65, Issue:9

    Topics: alpha-Synuclein; Animals; Humans; Intrinsically Disordered Proteins; Mammals; Neurodegenerative Dise

2022